- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Wockhardt Limited — Updates, 07-01-2026: Press Release
07-01-2026 | 09:04 am
07-01-2026 | 09:04 am
Wockhardt filed for EU market approval for its novel antibiotic WCK 5222 (Zaynich®). The application received Accelerated Assessment, signaling high medical need. This drug is also under fast-track review by US FDA, opening significant global market potential.
No comments yet. Be the first to comment!